Regnum Corp. Stock Other OTC
Equities
RGMP
US75915R1068
Biotechnology & Medical Research
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 3.1M |
---|---|---|---|---|---|
Net income 2021 | - | Net income 2022 | - | EV / Sales 2021 | - |
Net Debt 2021 | 22.06K | Net Debt 2022 | 773K | EV / Sales 2022 | - |
P/E ratio 2021 |
-13
x | P/E ratio 2022 |
-3.97
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 1.18% |
1st Jan change | Capi. | |
---|---|---|
+16.14% | 45.51B | |
-9.57% | 38.52B | |
+38.08% | 38.13B | |
+27.96% | 30.74B | |
-8.64% | 26.03B | |
+11.56% | 25.92B | |
+45.08% | 14.13B | |
+33.59% | 12.73B | |
-7.79% | 11.29B |